TrialFind
Saved trials
Back to results
Completed
Phase 3
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes
NCT01289119
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Beijing, Beijing Municipality, China
+20 additional locations
View on ClinicalTrials.gov
Official details
Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes — TrialFind